MedWatch: FDA Warns Risk of Transmission of Blood-borne Pathogens from Shared Use of Insulin Pens

The U.S. Food and Drug Administration today issued an alert to health care professionals reminding them that single-patient insulin pens and insulin cartridges should not be used to administer medication to multiple patients due to the potential risk of transmitting blood-borne pathogens such as HIV and the hepatitis viruses.

MORE ON THIS TOPIC